Pediatric Antibiotic Stewardship for Community-Acquired Pneumonia: A Pre-Post Intervention Study

Clin Pediatr (Phila). 2022 Nov;61(11):795-801. doi: 10.1177/00099228221102827. Epub 2022 Jun 8.

Abstract

We aimed to investigate the effectiveness of an antibiotic stewardship program (ASP) on antibiotic prescription in children with community-acquired pneumonia (CAP). Antibiotic purchasing data were collected for children aged 3 months to 18 years diagnosed with CAP from November 2016 to April 2017 (pre-intervention period) and from November 2017 to April 2018 (post-intervention period). The intervention was a 1-day seminar for primary care pediatricians on the diagnosis and treatment of CAP in children according to national guidelines. There was a substantial decrease in the use of azithromycin after the intervention. In younger children, there was a 42% decrease, alongside an increased use of amoxicillin (P < .001). In older children, there was a smaller, non-statistically significant decrease in the use of azithromycin (P = .45). Our data demonstrate that the implementation of an ASP was associated with a reduction in the use of broad-spectrum antibiotics and macrolides and increased guideline adherence for the safe treatment of CAP.

Keywords: children; community-acquired pneumonia; pediatric antibiotic stewardship; pediatric community health care centers.

MeSH terms

  • Amoxicillin
  • Anti-Bacterial Agents / therapeutic use
  • Antimicrobial Stewardship*
  • Azithromycin / therapeutic use
  • Child
  • Community-Acquired Infections* / drug therapy
  • Humans
  • Pneumonia* / drug therapy

Substances

  • Anti-Bacterial Agents
  • Amoxicillin
  • Azithromycin